Lantern Pharma to Showcase AI-Powered Cancer Drug Discovery and Development on RedChip Webinar on August 26.

RedChip Companies will host an investor webinar with Lantern Pharma on August 26, 2025. Lantern's CEO, Panna Sharma, will discuss the company's clinical pipeline, including LP-300, LP-184, and LP-284, and highlight its proprietary AI and machine learning platform, RADR®, which aims to compress early drug development timelines and reduce costs. Questions can be pre-submitted to LTRN@redchip.com or online during the live event.

RedChip Companies will host an exclusive investor webinar with Lantern Pharma Inc. (NASDAQ: LTRN) on August 26, 2025, at 4:15 p.m. ET. The webinar will provide insights into Lantern's innovative approach to cancer drug discovery and development through its proprietary AI and machine learning platform, RADR®.

Lantern Pharma's CEO, Panna Sharma, will spotlight the company's advancing clinical pipeline, including LP-300, LP-184, and LP-284. These drug candidates are in various stages of development and target significant markets with urgent unmet needs. LP-300, a Phase 2 Harmonic™ trial in never-smokers with NSCLC, addresses a $4B+ global market. LP-184, a Phase 1 therapy for DDR-deficient solid tumors, targets a $10B+ market. LP-284, a first-in-class drug candidate for aggressive lymphomas, has a market potential of $3.75-4B.

Lantern Pharma's RADR® platform analyzes over 200 billion oncology data points and leverages more than 200 advanced ML algorithms to compress early drug development timelines by up to 70% and reduce costs by 80%. The company has secured 11 FDA designations, an expanding ADC program, and collaborations with world-class cancer centers such as Johns Hopkins and MD Anderson, along with a growing patent estate of over 100 issued and pending patents.

The webinar will also feature a live Q&A session with management, allowing participants to ask questions directly. To register for the free webinar, please visit [RedChip Companies Webinar Page] [NUMBER:1].

References:
[1] https://www.newswire.com/news/redchip-to-host-exclusive-investor-webinar-featuring-lantern-pharma-on-august-26
[2] https://www.nasdaq.com/press-release/redchip-host-exclusive-investor-webinar-featuring-lantern-pharma-august-26-2025-08-19